Cargando…
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
ABCB1 is a member of the ATP binding cassette transporter family and high ABCB1 activity is considered as a poor prognostic factor in acute myeloid leukemia (AML) treated with intensive chemotherapy, its direct relation with drug resistance remains unclear. We evaluated ABCB1 activity in relation wi...
Autores principales: | Boyer, Thomas, Gonzales, Fanny, Barthélémy, Adeline, Marceau-Renaut, Alice, Peyrouze, Pauline, Guihard, Soizic, Lepelley, Pascale, Plesa, Adriana, Nibourel, Olivier, Delattre, Carole, Wetterwald, Marc, Pottier, Nicolas, Plantier, Isabelle, de Botton, Stéphane, Dombret, Hervé, Berthon, Céline, Preudhomme, Claude, Roumier, Christophe, Cheok, Meyling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770064/ https://www.ncbi.nlm.nih.gov/pubmed/31500210 http://dx.doi.org/10.3390/cancers11091323 |
Ejemplares similares
-
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016) -
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015) -
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype
por: Fenwarth, Laurène, et al.
Publicado: (2019) -
Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure
por: Lewuillon, Clara, et al.
Publicado: (2022) -
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
por: Fenwarth, Laurène, et al.
Publicado: (2020)